File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China

TitleImpact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China
Authors
KeywordsAcute myocardial infarction/STEMI
ACS/NSTEMI
Health care outcomes
Issue Date2020
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/journal/117934745/grouphome/home.html
Citation
Catheterization and Cardiovascular Interventions, 2020 How to Cite?
AbstractObjective: To determine whether COVID‐19 may adversely affect outcome of myocardial infarction (MI) patients in Hong Kong, China. Background: The COVID‐19 pandemic has infected thousands of people and placed enormous stress on healthcare system. Apart from being an infectious disease, it may affect human behavior and healthcare resource allocation which potentially cause treatment delay in MI. Methods: This was a single center cross‐sectional observational study. From November 1, 2019 to March 31, 2020, we compared outcome of patients admitted for acute ST‐elevation MI (STEMI) and non‐ST elevation MI (NSTEMI) before (group 1) and after (group 2) January 25, 2020 which was the date when Hong Kong hospitals launched emergency response measures to combat COVID‐19. Results: There was a reduction in daily emergency room attendance since January 25, 2020 (group 1,327/day vs. group 2,231/day) and 149 patients with diagnosis of MI were included into analysis (group 1 N = 85 vs. group 2 N = 64). For STEMI, patients in group 2 tended to have longer symptom‐to‐first medical contact time and more presented out of revascularization window (group 1 27.8 vs. group 2 33%). The primary composite outcome of in‐hospital death, cardiogenic shock, sustained ventricular tachycardia or fibrillation (VT/VF) and use of mechanical circulatory support (MCS) was significantly worse in group 2 (14.1 vs. 29.7%, p = .02). Conclusions: More MI patients during COVID‐19 outbreak had complicated in‐hospital course and worse outcomes. Besides direct infectious complications, cardiology community has to acknowledge the indirect effect of communicable disease on our patients and system of care.
Persistent Identifierhttp://hdl.handle.net/10722/287282
ISSN
2020 Impact Factor: 2.692
2020 SCImago Journal Rankings: 0.988
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorTam, CCF-
dc.contributor.authorCheung, KS-
dc.contributor.authorLam, S-
dc.contributor.authorWong, A-
dc.contributor.authorYung, A-
dc.contributor.authorSze, M-
dc.contributor.authorFang, J-
dc.contributor.authorTse, HF-
dc.contributor.authorSiu, CW-
dc.date.accessioned2020-09-22T02:58:37Z-
dc.date.available2020-09-22T02:58:37Z-
dc.date.issued2020-
dc.identifier.citationCatheterization and Cardiovascular Interventions, 2020-
dc.identifier.issn1522-1946-
dc.identifier.urihttp://hdl.handle.net/10722/287282-
dc.description.abstractObjective: To determine whether COVID‐19 may adversely affect outcome of myocardial infarction (MI) patients in Hong Kong, China. Background: The COVID‐19 pandemic has infected thousands of people and placed enormous stress on healthcare system. Apart from being an infectious disease, it may affect human behavior and healthcare resource allocation which potentially cause treatment delay in MI. Methods: This was a single center cross‐sectional observational study. From November 1, 2019 to March 31, 2020, we compared outcome of patients admitted for acute ST‐elevation MI (STEMI) and non‐ST elevation MI (NSTEMI) before (group 1) and after (group 2) January 25, 2020 which was the date when Hong Kong hospitals launched emergency response measures to combat COVID‐19. Results: There was a reduction in daily emergency room attendance since January 25, 2020 (group 1,327/day vs. group 2,231/day) and 149 patients with diagnosis of MI were included into analysis (group 1 N = 85 vs. group 2 N = 64). For STEMI, patients in group 2 tended to have longer symptom‐to‐first medical contact time and more presented out of revascularization window (group 1 27.8 vs. group 2 33%). The primary composite outcome of in‐hospital death, cardiogenic shock, sustained ventricular tachycardia or fibrillation (VT/VF) and use of mechanical circulatory support (MCS) was significantly worse in group 2 (14.1 vs. 29.7%, p = .02). Conclusions: More MI patients during COVID‐19 outbreak had complicated in‐hospital course and worse outcomes. Besides direct infectious complications, cardiology community has to acknowledge the indirect effect of communicable disease on our patients and system of care.-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/journal/117934745/grouphome/home.html-
dc.relation.ispartofCatheterization and Cardiovascular Interventions-
dc.subjectAcute myocardial infarction/STEMI-
dc.subjectACS/NSTEMI-
dc.subjectHealth care outcomes-
dc.titleImpact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China-
dc.typeArticle-
dc.identifier.emailTam, CCF: fcctam@hku.hk-
dc.identifier.emailLam, S: scclam@hku.hk-
dc.identifier.emailWong, A: wongyta@hku.hk-
dc.identifier.emailYung, A: asyyung@HKUCC-COM.hku.hk-
dc.identifier.emailTse, HF: hftse@hkucc.hku.hk-
dc.identifier.emailSiu, CW: cwdsiu@hkucc.hku.hk-
dc.identifier.authorityTse, HF=rp00428-
dc.identifier.authoritySiu, CW=rp00534-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/ccd.28943-
dc.identifier.pmid32367683-
dc.identifier.pmcidPMC7267252-
dc.identifier.scopuseid_2-s2.0-85084616938-
dc.identifier.hkuros314411-
dc.identifier.isiWOS:000530155300001-
dc.publisher.placeUnited States-
dc.identifier.issnl1522-1946-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats